In a report released yesterday, Srikripa Devarakonda from Truist Financial maintained a Buy rating on Bristol-Myers Squibb (BMY – Research ...

Truist raised the firm’s price target on Bristol Myers (BMY) to $65 from $62 and keeps a Buy rating on the shares as part of a broader research ...

We recently compiled a list of the Early Retirement Portfolio: 10 Stocks to Live Off Dividends. In this article, we are going ...

(Reuters) - The U.S. Food and Drug Administration said on Friday that it has approved an injectable version of Bristol Myers ...

Samsung Neo QLED 4K TV (QNX1D) is available with significant savings, including $1750 off the 85″ model, $1150 off the 75″ ...

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world ...

Day One Biopharmaceuticals focuses on pediatric cancer treatments. Read more about the biotech's therapies and its prospects ...

Legend Biotech is a commercial-stage biotech company specializing in innovative cell therapies. Click here to find out why I ...

This was the stock's second consecutive day of gains.

A New York appellate court on Tuesday denied President-elect Donald Trump's bid to halt sentencing set for Friday for his conviction on criminal charges stemming from hush money paid to a porn ...

A force fighting Sudan’s army in a brutal civil war committed massacres and rape that amount to genocide, the Secretary of State said, two decades after a finding of genocide in the same region ...

An Emboldened Trump Talks of Taking Greenland and Panama Canal by Force In a rambling news conference from his private Florida club, President-elect Trump refused to rule out using military force ...